Effects of triptolide on migration of vascular endothelial cells

Journal of Sichuan University (Medical Science)

Volumn 36, Issue 3, 2005, Pages 347-350

  Ding, Yi ^a   Zhao, Qing Liang ^a   Li, Yong Gang ^a   Zhang, Jie ^a   Wang, Qiu Lin ^a   Wang, Shu Ren ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Endothelial; Migration; Real time quantitive polymerase chain reaction; Triptolide; u PA

Indexed keywords

TRIPTOLIDE; UROKINASE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

EID: 19744368650     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Chen P, Li J, Barnes J, et al. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol, 2002;169(11):6408.
2. Hikim AP, Lue YH, Wang C, et al. Swerdloff RS. Posttesticular antifertility action of triptolide in the male rat: evidence for severe impairment of cauda epididymal sperm ultrastructure. J Androl, 2000;21(3):431.
3. Brodsky S, Chen J, Lee A, et al. Plasmin-dependent and - independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Am J Physiol Heart Circ Physiol, 2001; 281(4):H1784.
4. Copeta A, Tavian D, Marchina E, et al. Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators. Growth Factors, 2000;17(4):249.
5. Carmeliet P, Moons L, Dewerchin M, et al. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J Cell Biol, 1998;140 (1):233.
6. Duffy MJ. The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des, 2004;10(1):39.
7. Gallicchio MA, Kaun C, Wojta J, et al. urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro. J Cell Physi, 2003;197(1):131.